
Viagra-like pill could slow Alzheimer’s disease
A pill intended to treat erectile dysfunction could become the first pill to slow Alzheimer’s disease in the United States, reports the Washington Post. The drug, sold in South Korea as Mvix, slightly delayed cognitive decline during a year-long trial of more than 1,500 people with early-stage Alzheimer’s disease. The researchers found that the drug prevented the decline by just over three months compared to people taking a placebo, but they say this effect could become more pronounced as people continue to take the drug. One caveat: The benefit was only seen in those who were not taking other medications to relieve dementia symptoms.
South Korean company AriBio plans to ask the FDA whether the data is strong enough for approval or whether another major trial is needed. If approved, the low-dose, once-daily pill would offer an at-home alternative to existing antibody infusions, although outside experts stress the results are still preliminary. “It’s too early to say much definitively,” says neuroscientist Atticus Hainsworth of City St George’s, University of London. But the evidence “looks pretty good to me.” (A previous study suggested similar benefits for Viagra and other PDE5 inhibitor drugs.)
Gn bussni